A citation-based method for searching scientific literature


List of co-cited articles
57 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity






A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
41

Potential impact of a predictive test on the gene frequency of Huntington disease.
M Schoenfeld, R H Myers, B Berkman, E Clark. Am J Med Genet 1984
43
33

Genetic testing in Huntington's disease.
W C Koller, J Davenport. Ann Neurol 1984
18
33


Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
127
25



Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
158
25


Predictive test for Huntington's chorea.
H C Klawans, G W Paulson, A Barbeau. Lancet 1970
67
25

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
25








Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.
G Evers-Kiebooms, J J Cassiman, H van den Berghe. J Med Genet 1987
42
16



Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
180
16

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
237
16


Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration.
Petersén A, K E Larsen, G G Behr, N Romero, S Przedborski, P Brundin, D Sulzer. Hum Mol Genet 2001
156
16

Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
Liliana B Menalled, Jessica D Sison, Ying Wu, Melisa Olivieri, Xiao-Jiang Li, He Li, Scott Zeitlin, Marie-Françoise Chesselet. J Neurosci 2002
158
16

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
562
16


Huntington's Disease.
Donald S Higgins. Curr Treat Options Neurol 2006
6
33

Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.
Michel Cyr, Jean-Martin Beaulieu, Aki Laakso, Tatyana D Sotnikova, Wei-Dong Yao, Laura M Bohn, Raul R Gainetdinov, Marc G Caron. Proc Natl Acad Sci U S A 2003
114
16

Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity.
Shouqing Luo, Coralie Vacher, Janet E Davies, David C Rubinsztein. J Cell Biol 2005
130
16


Functional decline in Huntington's disease.
A Feigin, K Kieburtz, K Bordwell, P Como, K Steinberg, J Sotack, C Zimmerman, C Hickey, C Orme, I Shoulson. Mov Disord 1995
73
16

Selective sparing of a class of striatal neurons in Huntington's disease.
R J Ferrante, N W Kowall, M F Beal, E P Richardson, E D Bird, J B Martin. Science 1985
660
16


Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
Delphine Charvin, Peter Vanhoutte, Christiane Pagès, Emilliana Borrelli, Jocelyne Caboche. Proc Natl Acad Sci U S A 2005
91
16

Tetrabenazine treatment for Huntington's disease-associated chorea.
William G Ondo, Ron Tintner, Madhavi Thomas, Joseph Jankovic. Clin Neuropharmacol 2002
53
16

Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage.
Pierre-O Fernagut, Elsa Diguet, Mohamed Jaber, Bernard Bioulac, François Tison. Eur J Neurosci 2002
30
16

Factors associated with slow progression in Huntington's disease.
R H Myers, D S Sax, W J Koroshetz, C Mastromauro, L A Cupples, D K Kiely, F K Pettengill, E D Bird. Arch Neurol 1991
158
16



Tetrabenazine treatment in movement disorders.
D Paleacu, N Giladi, O Moore, A Stern, S Honigman, S Badarny. Clin Neuropharmacol 2004
60
16

Profound neuronal plasticity in response to inactivation of the dopamine transporter.
S R Jones, R R Gainetdinov, M Jaber, B Giros, R M Wightman, M G Caron. Proc Natl Acad Sci U S A 1998
501
16


Tetrabenazine in the treatment of hyperkinetic movement disorders.
Christopher Kenney, Joseph Jankovic. Expert Rev Neurother 2006
79
16

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
316
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.